p - Search

Clinical Trials

• P E P C A D II, The Paclitaxel-Eluting PTCA-Balloon Catheter in Coronary Artery Disease to Treat In-Stent Restenoses
  ClinicalTrials.gov Identifier: NCT00393315 - Active, not recruiting
  In-Stent Restenosis
  
• P-glycoprotein Antagonist, Tariquidar, in Combination with Doxorubicin (Adriamycin), Vinorelbine (Navelbine), or Docetaxel to Treat Children with Solid Tumors
  ClinicalTrials.gov Identifier: NCT00011414 - Recruiting
  Brain Tumor; Ewing's Sarcoma; Neuroblastoma; Rhabdomyosarcoma
  
• P-Glycoprotein Inhibition as Adjunct Treatment for Medically Refractory Epilepsy.
  ClinicalTrials.gov Identifier: NCT00524134 - Not yet recruiting
  Epilepsy
  
• P210-B3A2 Derived Peptide Vaccine in CML
  ClinicalTrials.gov Identifier: NCT00452933 - Recruiting
  Chronic Myeloid Leukemia
  
• P3: Pacemaker Patient Profiling Study
  ClinicalTrials.gov Identifier: NCT00294060 - Active, not recruiting
  Bradycardia
  
• P4 (Pregabalin for Peripheral Posttraumatic Pain)
  ClinicalTrials.gov Identifier: NCT00292188 - Recruiting
  Neuralgia
  
• p450 Mediated Lung Toxicity
  ClinicalTrials.gov Identifier: NCT00023114 - Completed
  Pulmonary Disease
  
• p53 Peptide vaccination for Breast or Ovary Cancer
  ClinicalTrials.gov Identifier: NCT00001828 - Recruiting
  Breast Cancer; Breast Neoplasm
  
• p53 Peptide Vaccination to Treat Lung Cancer
  ClinicalTrials.gov Identifier: NCT00001829 - No longer recruiting
  Non-Small-Cell Lung Carcinoma
  
• p53 Vaccine for Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00001827 - No longer recruiting
  Ovarian Neoplasm
  
• p53 Vaccine in Treating Patients With Adenocarcinoma of the Ovary Who Have Either No Evidence of Disease or Elevated Biomarkers
  ClinicalTrials.gov Identifier: NCT00019903 - Active, not recruiting
  Ovarian Cancer
  
• p53-Adjusted Neoadjuvant Chemotherapy for Potentially Resectable Oesophageal Cancer
  ClinicalTrials.gov Identifier: NCT00525200 - Recruiting
  Oesophageal Cancer
  
• PA-824-CL-007: Phase IIa Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis
  ClinicalTrials.gov Identifier: NCT00567840 - Completed
  Pulmonary Tuberculosis
  
• PACAP38´s Headache Inducing Characteristics and Effects on the Cerebral Blood Flow
  ClinicalTrials.gov Identifier: NCT00380263 - Recruiting
  Migraine Without Aura
  
• PACE-iDP: An Intervention for Youth at Risk for Diabetes
  ClinicalTrials.gov Identifier: NCT00412165 - Recruiting
  Obesity; Overweight; Diabetes
  
• PACE-PC: Primary Care Management of Adolescent Obesity
  ClinicalTrials.gov Identifier: NCT00415974 - Not yet recruiting
  Obesity; Overweight; Weight Loss; Weight Maintenance
  
• Pacemaker Therapy in Adults With Congenital Heart Defects
  ClinicalTrials.gov Identifier: NCT00303511 - Terminated
  Congenital Disorder
  
• PACEPro - Mood Management Pilot
  ClinicalTrials.gov Identifier: NCT00416221 - Active, not recruiting
  Depression
  
• Pacing of the Atria in Sick Sinus Syndrome Trial Preventive Strategies for Atrial Fibrillation
  ClinicalTrials.gov Identifier: NCT00161538 - Completed
  Sick Sinus Syndrom
  
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00521313 - Recruiting
  Lung Cancer
  
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine in Treating Patients With Advanced Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00307255 - Active, not recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Pemetrexed in Treating Patients With Advanced Non-Small Cell Lung Cancer, Breast Cancer, or Other Solid Tumors
  ClinicalTrials.gov Identifier: NCT00470548 - Recruiting
  Breast Cancer; Lung Cancer; Unspecified Adult Solid Tumor, Protocol Specific
  
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00499291 - Not yet recruiting
  Cancer
  
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00499252 - Recruiting
  Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
  
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Bevacizumab, and Gemcitabine as First-Line Therapy in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00503906 - Recruiting
  Breast Cancer
  
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Carboplatin, and Radiation Therapy in Treating Patients With Stage III Non-Small-Cell Lung Cancer That Cannot Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00544648 - Recruiting
  Lung Cancer
  
• Paclitaxel and ABI-007 in Treating Patients With Locally Advanced or Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00095914 - Active, not recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Paclitaxel and BMS-214662 in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00006018 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Paclitaxel and Bryostatin 1 in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00005028 - Completed
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• Paclitaxel and Bryostatin-1 in Treating Patients With Locally Advanced Unresectable or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00031694 - Active, not recruiting
  stage II pancreatic cancer; stage III pancreatic cancer; recurrent pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer; ...
  
• Paclitaxel and Capecitabine in Patients With Metastatic/Recurrence Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00453323 - Recruiting
  Esophageal Cancer
  
• Paclitaxel and Capecitabine in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00005649 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Paclitaxel and Carboplatin Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer That Cannot Be Removed During Surgery
  ClinicalTrials.gov Identifier: NCT00004887 - Active, not recruiting
  stage IIIA non-small cell lung cancer; stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer
  
• Paclitaxel and Carboplatin Followed by Cisplatin and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00462397 - Recruiting
  Cervical Cancer
  
• Paclitaxel and Carboplatin in Treating Patients With Locally Advanced or Metastatic Renal Cell Cancer
  ClinicalTrials.gov Identifier: NCT00077129 - Active, not recruiting
  stage III renal cell cancer; Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• Paclitaxel and Carboplatin in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00049257 - Recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer
  
• Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or IV Uterine Cancer
  ClinicalTrials.gov Identifier: NCT00112489 - Recruiting
  recurrent uterine sarcoma; stage III uterine sarcoma; stage IV uterine sarcoma; uterine carcinosarcoma
  
• Paclitaxel and Carboplatin in Treating Women Who are Undergoing Surgery for Newly Diagnosed, Locally Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00096343 - Active, not recruiting
  invasive ductal breast carcinoma; invasive lobular breast carcinoma; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; ...
  
• Paclitaxel and Carboplatin or Temozolomide in Treating Patients With Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00568451 - Recruiting
  Melanoma (Skin)
  
• Paclitaxel and Carboplatin With or Without AZD2171 in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00245154 - Recruiting
  Lung Cancer
  
• Paclitaxel and Carboplatin With or Without BMS-275291 in Treating Patients With Advanced or Metastatic Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00006229 - Active, not recruiting
  stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer
  
• Paclitaxel and Carboplatin With or Without Celecoxib Before Surgery in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00062179 - Active, not recruiting
  stage IIIA non-small cell lung cancer
  
• Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00004934 - Completed
  stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; Fallopian Tube Cancer; ...
  
• Paclitaxel and Carboplatin With Or Without Sorafenib In The First-Line Treatment Of Patients With Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00390611 - Recruiting
  Ovarian Cancer
  
• Paclitaxel and Celecoxib in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00084448 - Completed
  recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00002717 - Active, not recruiting
  ovarian serous cystadenocarcinoma; ovarian endometrioid adenocarcinoma; peritoneal cavity cancer; ovarian mixed epithelial carcinoma; ...
  
• Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung Cancer
  ClinicalTrials.gov Identifier: NCT00021333 - Active, not recruiting
  Lung Cancer; Salivary Gland Cancer; lip and oral cavity cancer; Head and Neck Cancer; Thyroid Cancer; Oropharyngeal Cancer
  
• Paclitaxel and Estramustine in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00021372 - Active, not recruiting
  recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult diffuse small cleaved cell lymphoma; ...
  
• Paclitaxel and GEM 231 in Treating Patients With Recurrent or Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00004863 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Paclitaxel and GM-CSF in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00278122 - Recruiting
  Melanoma (Skin)
  
• Paclitaxel and Hyperthermic Perfusion in Treating Patients With Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00020007 - Completed
  Lung Cancer; Metastatic Cancer
  
• Paclitaxel and Irinotecan in Treating Patients With Advanced Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00004924 - Active, not recruiting
  stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
  
• Paclitaxel and Oxaliplatin in Treating Patients With Recurrent or Advanced Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00004126 - Active, not recruiting
  stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer; recurrent non-small cell lung cancer
  
• Paclitaxel and Radiation Therapy Plus Chemoprotection With Amifostine in Treating Patients With Stage III or Stage IV Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003193 - Active, not recruiting
  Oral Cancer; Throat Cancer
  
• Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00238420 - Recruiting
  Bladder Cancer
  
• Paclitaxel Coated Balloon Catheter for Prevention of Restenosis in Femoropopliteal Arteries
  ClinicalTrials.gov Identifier: NCT00472472 - Active, not recruiting
  Peripheral Arterial Disease
  
• Paclitaxel Combined With Fluorouracil-Uracil and Leucovorin in Treating Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00009828 - Completed
  unspecified adult solid tumor, protocol specific
  
• Paclitaxel Compared With Doxorubicin in Treating Patients With Advanced AIDS-Related Kaposi's Sarcoma
  ClinicalTrials.gov Identifier: NCT00003350 - Active, not recruiting
  epidemic Kaposi's sarcoma
  
• Paclitaxel Eluting Covered Metalic Stent for Uresectable Malignant Bile Duct Obstruction
  ClinicalTrials.gov Identifier: NCT00453076 - Recruiting
  Bile Duct Obstruction
  
• Paclitaxel in Advanced Refractory Kaposi's Sarcoma (AIDS-KS): A Phase II Trial of Paclitaxel from Baker Norton Pharmaceuticals
  ClinicalTrials.gov Identifier: NCT00002189 - Completed
  Sarcoma, Kaposi; HIV Infections
  
• Paclitaxel in Treating Older Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003092 - Completed
  unspecified adult solid tumor, protocol specific
  
• Paclitaxel in Treating Patients With Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00002922 - Completed
  stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity; stage IV squamous cell carcinoma of the lip and oral cavity; ...
  
• Paclitaxel in Treating Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission
  ClinicalTrials.gov Identifier: NCT00003120 - Active, not recruiting
  stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; peritoneal cavity cancer; ...
  
• Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal Cancer
  ClinicalTrials.gov Identifier: NCT00002562 - Completed
  recurrent vaginal cancer; recurrent cervical cancer; cervical adenocarcinoma; vaginal clear cell adenocarcinoma
  
• Paclitaxel in Treating Patients With AIDS-Related Kaposi's Sarcoma
  ClinicalTrials.gov Identifier: NCT00003008 - Active, not recruiting
  epidemic Kaposi's sarcoma; recurrent Kaposi's sarcoma
  
• Paclitaxel in Treating Patients With Early-Stage Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00002917 - Completed
  transitional cell carcinoma of the bladder; stage I bladder cancer; stage 0 bladder cancer
  
• Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00005646 - Completed
  extensive stage small cell lung cancer
  
• Paclitaxel in Treating Patients With Locally Advanced or Metastatic Soft Tissue Angiosarcoma or Lymphangiosarcoma That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00217607 - Recruiting
  Sarcoma
  
• Paclitaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Vulva
  ClinicalTrials.gov Identifier: NCT00014599 - Active, not recruiting
  stage III vulvar cancer; stage IV vulvar cancer; recurrent vulvar cancer; squamous cell carcinoma of the vulva
  
• Paclitaxel in Treating Patients With Lung Cancer
  ClinicalTrials.gov Identifier: NCT00002972 - Active, not recruiting
  stage IIIB non-small cell lung cancer; recurrent non-small cell lung cancer; stage IV non-small cell lung cancer; Adenocarcinoma of the Lung
  
• Paclitaxel in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer
  ClinicalTrials.gov Identifier: NCT00002632 - Completed
  stage IV salivary gland cancer; recurrent salivary gland cancer; high-grade salivary gland mucoepidermoid carcinoma; salivary gland adenocarcinoma
  
• Paclitaxel in Treating Patients With Metastatic, Recurrent, or Unresectable Cancer of the Esophagus
  ClinicalTrials.gov Identifier: NCT00003326 - Active, not recruiting
  stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent esophageal cancer; Quality of Life; squamous cell carcinoma of the esophagus
  
• Paclitaxel in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00023907 - Completed
  recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Paclitaxel in Treating Patients With Ovarian Stromal Cancer
  ClinicalTrials.gov Identifier: NCT00006227 - Recruiting
  ovarian stromal cancer
  
• Paclitaxel in Treating Patients With Recurrent or Persistent Cancer of the Uterus
  ClinicalTrials.gov Identifier: NCT00003054 - Completed
  uterine leiomyosarcoma; recurrent uterine sarcoma
  
• Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00005046 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Paclitaxel in Treating Patients With Recurrent or Progressive Advanced Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00002928 - Completed
  recurrent ovarian epithelial cancer
  
• Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003327 - Active, not recruiting
  Nose Cancer; Oral Cancer
  
• Paclitaxel in Treating Patients With Recurrent or Refractory Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00004265 - Active, not recruiting
  recurrent non-small cell lung cancer
  
• Paclitaxel in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00003230 - Active, not recruiting
  untreated adult acute myeloid leukemia; untreated adult acute lymphocytic leukemia; recurrent adult acute myeloid leukemia; ...
  
• Paclitaxel in Treating Patients With Refractory or Recurrent Endometrial Cancer
  ClinicalTrials.gov Identifier: NCT00022620 - Active, not recruiting
  recurrent endometrial cancer; endometrial papillary carcinoma
  
• Paclitaxel in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00002969 - Active, not recruiting
  stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer; recurrent non-small cell lung cancer
  
• Paclitaxel in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00111904 - Recruiting
  stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer; recurrent pancreatic cancer
  
• Paclitaxel in Treating Women With Recurrent Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003130 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Paclitaxel or Docetaxel in Treating Women With Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002662 - Completed
  stage IV breast cancer; stage IIIA breast cancer; recurrent breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
  
• Paclitaxel or Polyglutamate Paclitaxel in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00108745 - Recruiting
  ovarian epithelial cancer; peritoneal cavity cancer
  
• Paclitaxel Plus Carboplatin With or Without SCH-58500 in Treating Patients With Newly Diagnosed Stage III Ovarian or Stage III Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00003880 - Completed
  ovarian serous cystadenocarcinoma; ovarian endometrioid adenocarcinoma; peritoneal cavity cancer; ovarian mixed epithelial carcinoma; ...
  
• Paclitaxel Plus Carboplatin With or Without Topotecan in Treating Patients With Stage IIB, Stage III, or Stage IV Ovarian Epithelial Cancer
  ClinicalTrials.gov Identifier: NCT00006454 - Active, not recruiting
  stage II ovarian epithelial cancer; Fallopian Tube Cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
  
• Paclitaxel Plus Chemoprotection With Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003555 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003614 - Completed
  stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer; Quality of Life
  
• Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003717 - Active, not recruiting
  stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer; Quality of Life
  
• Paclitaxel Plus Gemcitabine in Treating Patients With Refractory Metastatic Germ Cell Tumors
  ClinicalTrials.gov Identifier: NCT00003518 - Active, not recruiting
  recurrent testicular cancer; recurrent ovarian germ cell tumor; stage IV ovarian germ cell tumor; stage III testicular cancer
  
• Paclitaxel Plus L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphomas
  ClinicalTrials.gov Identifier: NCT00004057 - Active, not recruiting
  Cancer
  
• Paclitaxel Plus Monoclonal Antibody Therapy in Treating Women With Recurrent or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003539 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Paclitaxel Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma
  ClinicalTrials.gov Identifier: NCT00031577 - Active, not recruiting
  untreated childhood brain stem glioma
  
• Paclitaxel Plus Radiation Therapy in Treating Patients With Untreated Stage III Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00002519 - Active, not recruiting
  stage IIIB non-small cell lung cancer; stage IIIA non-small cell lung cancer
  
• Paclitaxel Plus Radiation Therapy in Treating Women With Stage II or Stage III Breast Cancer
  ClinicalTrials.gov Identifier: NCT00006256 - Active, not recruiting
  stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
  
• Paclitaxel Plus Topotecan in Treating Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00002587 - Completed
  unspecified adult solid tumor, protocol specific
  
• Paclitaxel Poliglumex and Capecitabine in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00265733 - Active, not recruiting
  Male Breast Cancer; Recurrent Breast Cancer; Stage IV Breast Cancer
  
• Paclitaxel Poliglumex and Estradiol in Treating Patients With Stage IV Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00459810 - Recruiting
  Prostate Cancer
  
• Paclitaxel With or Without Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00028990 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer; Male Breast Cancer
  
• Paclitaxel With or Without Carboplatin in Treating Patients With Advanced Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00003117 - Active, not recruiting
  stage IIIB non-small cell lung cancer; recurrent non-small cell lung cancer; stage IV non-small cell lung cancer; Adenosquamous Cell Lung Cancer; ...
  
• Paclitaxel With or Without Carboplatin in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00025688 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Paclitaxel With or Without Gemcitabine in Treating Women With Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00006459 - Completed
  stage IIIB breast cancer; stage IIIA breast cancer; stage IV breast cancer; recurrent breast cancer
  
• Paclitaxel With Or Without GW572016 As First Line Therapy For Women With Advanced Or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00075270 - Active, not recruiting
  Metastatic breast cancer
  
• Paclitaxel With or Without PSC 833 in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002937 - Active, not recruiting
  recurrent breast cancer
  
• Paclitaxel With or Without Sorafenib in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00499525 - Recruiting
  Breast Cancer
  
• Paclitaxel With or Without Trastuzumab Following Peripheral Stem Cell Transplantation in Treating Patients With Refractory Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00004013 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Paclitaxel With or Without Trastuzumab in Treating Patients With Inoperable, Recurrent, or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003440 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer; stage IIIB breast cancer
  
• Paclitaxel(Phyxol) and Cisplatin as First-Line Chemotherapy for Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00154882 - Recruiting
  Breast Cancer
  
• Paclitaxel, Carboplatin and Gemcitabine in the Treatment of Patients with Advanced Transitional Cell Cancer of the Bladder
  ClinicalTrials.gov Identifier: NCT00136175 - Active, not recruiting
  Bladder Cancer
  
• Paclitaxel, Carboplatin And Low Dose Radiation As Induction Therapy In Locally Advanced Head And Neck Cancer
  ClinicalTrials.gov Identifier: NCT00176267 - Active, not recruiting
  Squamous Cell Carcinoma
  
• Paclitaxel, Carboplatin and Radiotherapy as Induction Therapy in Locally Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00176254 - Active, not recruiting
  Squamous Cell Carcinoma
  
• Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00085501 - Active, not recruiting
  recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer; Adenocarcinoma of the Lung; ...
  
• Paclitaxel, Carboplatin, and Oral Etoposide Followed by Weekly Paclitaxel in High Grade Neuroendocrine Carcinoma
  ClinicalTrials.gov Identifier: NCT00193531 - Active, not recruiting
  Neuroendocrine Carcinoma
  
• Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients Who are Undergoing Surgery for Stage III Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00096226 - Recruiting
  stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer
  
• Paclitaxel, Carboplatin, and Radiation Therapy With or Without Adjuvant Paclitaxel and Carboplatin in Treating Patients With Stage II or Stage III Unresectable Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00077220 - Active, not recruiting
  stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer
  
• Paclitaxel, Carboplatin, and Topotecan in Patients with Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00102375 - Completed
  Ovarian Cancer
  
• Paclitaxel, Cisplatin, and Filgrastim Combined With Radiation Therapy in Treating Patients With Locally Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00005087 - Completed
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; metastatic squamous neck cancer with occult primary; Oropharyngeal Cancer; ...
  
• Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00002913 - Completed
  Ovarian Cancer
  
• Paclitaxel, Cisplatin, Gefitinib, and Radiation Therapy Followed by Surgery and Gefitinib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction That Can Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00493025 - Recruiting
  Esophageal Cancer
  
• Paclitaxel, Cyclophosphamide, and Doxorubicin Followed by Autologous Dendritic Cells and Surgery With or Without Radiation Therapy and/or Hormone Therapy in Treating Women With Stage II or Stage III Breast Cancer
  ClinicalTrials.gov Identifier: NCT00499083 - Recruiting
  Breast Cancer
  
• Paclitaxel, Estramustine, and Thalidomide in Treating Patients With Progressive Metastatic Androgen-Independent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00082693 - Active, not recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer
  
• Paclitaxel, Folic Acid, and Lometrexol in Treating Patients With Locally Advanced or Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00024310 - Active, not recruiting
  Drug Toxicity; unspecified adult solid tumor, protocol specific
  
• Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to Cisplatin
  ClinicalTrials.gov Identifier: NCT00423852 - Recruiting
  Brain and Central Nervous System Tumors; Extragonadal Germ Cell Tumor; Ovarian Cancer; Teratoma; Testicular Germ Cell Tumor
  
• Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Metastatic Testicular Cancer
  ClinicalTrials.gov Identifier: NCT00004077 - Active, not recruiting
  Testicular Cancer; Reproductive Cancer
  
• Paclitaxel, Topotecan, and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00276796 - Not yet recruiting
  Cervical Cancer
  
• Paclitaxel, Topotecan, and Estramustine in Treating Patients With Metastatic Hormone-Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00084565 - Completed
  stage IV prostate cancer; adenocarcinoma of the prostate
  
• Paclitaxel-Eluting Balloon Angioplasty and Coroflex™-Stents in the Treatment of Bifurcated Coronary Lesions
  ClinicalTrials.gov Identifier: NCT00540813 - Recruiting
  Ischemia; Stenosis
  
• Paclitaxel-HDFL for Locally Advanced and Recurrent/Metastatic Gastric Cancers
  ClinicalTrials.gov Identifier: NCT00154726 - Completed
  Locally Advanced and Recurrent/Metastatic Gastric Cancer
  
• Paclitaxel/Carboplatin Plus Bevacizumab/Erlotinib in the First Line Treatment of Carcinoma of Unknown Primary Site
  ClinicalTrials.gov Identifier: NCT00360360 - Recruiting
  Neoplasm, Unknown Primary
  
• Paclitaxel/Cyclophosphamide and High-Dose Melphalan/Etoposide Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage IIIB Inflammatory Breast Cancer
  ClinicalTrials.gov Identifier: NCT00019162 - Recruiting
  Breast Cancer
  
• PACMAN
  ClinicalTrials.gov Identifier: NCT00180596 - Completed
  Heart Failure
  
• PACT: Providers and Alzheimer's Caregivers Together
  ClinicalTrials.gov Identifier: NCT00182897 - Completed
  Alzheimer's Disease; Dementia
  
• PAD Combination Therapy Followed by Thal/Dex for Relapsed or Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00319865 - Recruiting
  Multiple Myeloma
  
• PADRE - Preventing Antibiotic-Associated DiarRhea Using Erceflora
  ClinicalTrials.gov Identifier: NCT00447161 - Recruiting
  Diarrhea, Infantile
  
• Pain and Sensory Changes Assessment in HIV+ Patients
  ClinicalTrials.gov Identifier: NCT00422695 - Recruiting
  HIV Infections
  
• Pain and Stress Management for People with Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00088764 - Active, not recruiting
  Rheumatoid Arthritis
  
• Pain Assessment, Incidence & Nature in Heart Failure
  ClinicalTrials.gov Identifier: NCT00444301 - Recruiting
  Heart Diseases
  
• Pain Control in Patients With Recurrent or Metastatic Breast or Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00002668 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer; stage IV prostate cancer; recurrent prostate cancer; Pain
  
• Pain Detection and Interception in Neonates
  ClinicalTrials.gov Identifier: NCT00447824 - Recruiting
  Pain Detection; Pain Intervention
  
• Pain Evaluation and Treatment
  ClinicalTrials.gov Identifier: NCT00362167 - Completed
  Pain
  
• Pain in Cancer Survivors
  ClinicalTrials.gov Identifier: NCT00581724 - Recruiting
  Breast Cancer; Colorectal Cancer; Prostate Cancer; Head and Neck Cancer; Lung Cancer
  
• Pain in Sickle Cell Epidemiologic Study
  ClinicalTrials.gov Identifier: NCT00035763 - Active, not recruiting
  Blood Disease; Anemia, Sickle Cell
  
• Pain Management and Behavioral Outcomes in Patients with Dementia
  ClinicalTrials.gov Identifier: NCT00012857 - Completed
  Dementia; Alzheimer Disease; Pain
  
• Pain Management Following TRAM Flap for Breast Reconstruction
  ClinicalTrials.gov Identifier: NCT00500565 - Recruiting
  Breast Cancer
  
• Pain Management for Pectus Excavatum Repair
  ClinicalTrials.gov Identifier: NCT00413582 - Recruiting
  Postoperative Pain
  
• Pain Management Protocol for Pediatric Sickle Cell Disease
  ClinicalTrials.gov Identifier: NCT00386048 - Recruiting
  Sickle Cell Disease
  
• Pain Management Techniques for Fibromyalgia
  ClinicalTrials.gov Identifier: NCT00086060 - Recruiting
  Fibromyalgia
  
• Pain Measurement
  ClinicalTrials.gov Identifier: NCT00001597 - Completed
  Healthy; Pain
  
• Pain of Injection of Lipuro Propofol in Children Aged 1-7 Years
  ClinicalTrials.gov Identifier: NCT00232895 - Completed
  ASA 1-2 Requiring Intravenous Cannulation for General Anaesthesia
  
• Pain Pathways in the Brain
  ClinicalTrials.gov Identifier: NCT00078364 - Completed
  Healthy; Tooth Extraction
  
• Pain Perception in Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00192816 - Recruiting
  Dementia Alzheimer Type
  
• Pain Perception is Attenuated in Patients With Painless Myocardial Infarction
  ClinicalTrials.gov Identifier: NCT00192790 - Completed
  Myocardial Infarction; Myocardial Ischemia
  
• Pain Post Abdominal Laparoscopy Prevention With Arcoxia
  ClinicalTrials.gov Identifier: NCT00565682 - Completed
  Laparoscopic Surgery for Appendicitis; Laparoscopic Surgery for Cholecystitis; Laparoscopic Surgery for Ovarian Cysts
  
• Pain Prevalence in the Trauma Population
  ClinicalTrials.gov Identifier: NCT00552968 - Recruiting
  Trauma
  
• Pain Processing in Anxiety and Depression
  ClinicalTrials.gov Identifier: NCT00560196 - Recruiting
  Pain; Anxiety; Depression
  
• Pain Quantification and Pain Management in Interventional Radiology
  ClinicalTrials.gov Identifier: NCT00500942 - Recruiting
  Pain
  
• Pain Reducing Effect of Transcutaneous Electrical Nerve Stimulation in Patients With Chronic Low Back Pain or Lumbo-Radiculalgia
  ClinicalTrials.gov Identifier: NCT00452010 - Recruiting
  Chronic Low Back Pain; Chronic Lumbo-Radiculalgia
  
• Pain Relief - Tramadol versus Ibuprofen
  ClinicalTrials.gov Identifier: NCT00111046 - Active, not recruiting
  Choroidal melanoma; Melanoma; Eye Neoplasms
  
• Pain Relief by Applying TENS on Acupuncture Points During the First Stage of Labour
  ClinicalTrials.gov Identifier: NCT00148577 - Active, not recruiting
  Pain relief at first stage
  
• Pain Relief by Intra-Peritoneal Ropivacaine During Gynecological Laparoscopy
  ClinicalTrials.gov Identifier: NCT00433316 - Recruiting
  Laparoscopic Surgical Procedures
  
• Pain Relief for Children Undergoing Tonsillectomy & Adenoidectomy
  ClinicalTrials.gov Identifier: NCT00468052 - Recruiting
  Obstructive Sleep Apnea
  
• Pain Relief Investigation of NeuroModulation Therapy in Adult Humans
  ClinicalTrials.gov Identifier: NCT00253032 - Terminated
  Chronic Musculoskeletal Pain
  
• Pain Relief Investigation of Neuromodulation Therapy in an Adult Fibromyalgia Population
  ClinicalTrials.gov Identifier: NCT00450905 - Recruiting
  Fibromyalgia; Pain
  
• Pain Relief Results After Anterior Cruciate Ligament (ACL) Reconstruction
  ClinicalTrials.gov Identifier: NCT00022854 - Completed
  Anterior Cruciate Ligament Rupture
  
• Pain Study of Rectus Muscle Closure at Cesarean Delivery
  ClinicalTrials.gov Identifier: NCT00505362 - Recruiting
  Pain; Complications; Adhesions
  
• Pain Study to See if Ultram ER Will Provide Relief to Subjects Whose Pain is Not Well Controlled by Narcotics
  ClinicalTrials.gov Identifier: NCT00505531 - Recruiting
  Chronic Pain
  
• Pain Treatment After Total Knee Replacement - Continuous Epidural Versus Intravenous Patient Controlled Analgesia With Morphine
  ClinicalTrials.gov Identifier: NCT00270322 - Terminated
  Total Knee Replacement; Orthopedic Surgery; Pain, Postoperative; Osteoarthritis
  
• Pain Treatment for Sciatica
  ClinicalTrials.gov Identifier: NCT00009672 - Completed
  Radiculopathy; Sciatica
  
• Painful HIV Neuropathy and Alpha-Lipoic Acid
  ClinicalTrials.gov Identifier: NCT00079807 - Active, not recruiting
  HIV; Peripheral Neuropathy
  
• Painful Procedures in the Emergency Department: A Distraction Intervention
  ClinicalTrials.gov Identifier: NCT00338364 - Recruiting
  Pediatric Pain and Anxiety
  
• Painful Procedures in the Emergency Department: A Distraction Intervention (3-5 Year Olds)
  ClinicalTrials.gov Identifier: NCT00337870 - Recruiting
  Anxiety; Pain
  
• Paired-Comparison Study Evaluating the Efficacy and Safety of E6201 Versus Vehicle for the Treatment of Plaque-Type Psoriasis
  ClinicalTrials.gov Identifier: NCT00539929 - Not yet recruiting
  Chronic Plaque Psoriasis
  
• Paleolithic Diet and Exercise Study
  ClinicalTrials.gov Identifier: NCT00360516 - Recruiting
  Healthy
  
• Paleolithic Diet in the Treatment of Diabetes Type 2 in Primary Health Care
  ClinicalTrials.gov Identifier: NCT00435240 - Recruiting
  Diabetes Mellitus, Type 2
  
• Paleolithic Diet in the Treatment of Glucose Intolerance
  ClinicalTrials.gov Identifier: NCT00419497 - Completed
  Hyperglycemia; Coronary Heart Disease
  
• Paleolithic Diets and T2D
  ClinicalTrials.gov Identifier: NCT00548782 - Recruiting
  Type 2 Diabetes Mellitus
  
• Palifermin After Haploidentical PBSCT
  ClinicalTrials.gov Identifier: NCT00570999 - Not yet recruiting
  Non-Hodgkin's Lymphoma or Hodgkin's Disease; Acute Leukaemia; Myelodysplastic Syndrome; Chronic Myeloid Leukemia; Osteomyelofibrosis
  
• Palifermin DDI (Drug Drug Interaction)
  ClinicalTrials.gov Identifier: NCT00361348 - Completed
  Healthy Volunteers
  
• Palifermin for the Reduction of Oral Mucositis in Single-dose Evaluation (PROMISE)
  ClinicalTrials.gov Identifier: NCT00109031 - Active, not recruiting
  Cancer; Lymphoma; Leukemia
  
• Palifermin in Lessening Oral Mucositis in Patients Undergoing Radiation Therapy and Chemotherapy for Locally Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00360971 - Recruiting
  Head and Neck Cancer; Mucositis; Pain; Radiation Toxicity
  
• Palifermin in Reducing or Preventing Mucositis in Patients Who Are Receiving Radiation Therapy and Chemotherapy Followed by an Autologous Stem Cell Transplant for Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00126529 - Recruiting
  Drug Toxicity; Leukemia; Lymphoma; oral complications of cancer and cancer therapy; plasma cell neoplasm; radiation toxicity
  
• Paliperidone ER Study of Economic, Functional, and Clinical Outcomes.
  ClinicalTrials.gov Identifier: NCT00488891 - Recruiting
  Schizophrenia
  
• Palladium-103 Seed Implant and Single Daily Dosing of Uroxatral Vs. Twice Daily Dosing of Flomax- A 3 Month Retrospective Efficacy Analysis
  ClinicalTrials.gov Identifier: NCT00264017 - Completed
  Prostate Cancer Patients Undergoing External Radiation and Seed Implantation
  
• Palliative Care Efficacy Study in Patients with Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00127517 - Recruiting
  Palliative Cancer Care; Advanced Cancer
  
• Palliative Care of Children With End-Stage Heart Failure
  ClinicalTrials.gov Identifier: NCT00327782 - Terminated
  Congenital Disorders
  
• Palliative Chemotherapy in Treating Patients With Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00002893 - Active, not recruiting
  recurrent colon cancer; stage III rectal cancer; Stage IV rectal cancer; adenocarcinoma of the rectum; recurrent rectal cancer; ...
  
• Palliative Oxygen for the Relief of Breathlessness
  ClinicalTrials.gov Identifier: NCT00327873 - Recruiting
  Dyspnea
  
• Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant Mesothelioma
  ClinicalTrials.gov Identifier: NCT00030459 - Active, not recruiting
  localized malignant mesothelioma; advanced malignant mesothelioma; recurrent malignant mesothelioma
  
• Pallidal Stimulation and Gilles de la Tourette Syndrome
  ClinicalTrials.gov Identifier: NCT00478842 - Not yet recruiting
  Gilles de la Tourette Syndrome
  
• Pallidal Stimulation in Patients With Idiopathic Generalised Dystonia
  ClinicalTrials.gov Identifier: NCT00169403 - Recruiting
  Dystonia
  
• Pallidal Stimulation in Patients With Post-Anoxic and Idiopathic Dystonia
  ClinicalTrials.gov Identifier: NCT00169338 - Recruiting
  Dystonia
  
• Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer
  ClinicalTrials.gov Identifier: NCT00553059 - Recruiting
  Nausea and Vomiting; Unspecified Adult Solid Tumor, Protocol Specific
  
• Palonosetron for Prevention of Biochemotherapy Induced Nausea and Vomiting
  ClinicalTrials.gov Identifier: NCT00412425 - Recruiting
  Melanoma
  
• Palonosetron in Sarcoma Patients Receiving Chemotherapy With Adriamycin and Ifosfamide (AI)
  ClinicalTrials.gov Identifier: NCT00410488 - Recruiting
  Sarcoma; Nausea; Vomiting
  
• PALUREA: Severe Imported Malaria in Adults
  ClinicalTrials.gov Identifier: NCT00372684 - Recruiting
  Malaria
  
• Pamidronate Administration in Breast Cancer Patients with Bone Metastases.
  ClinicalTrials.gov Identifier: NCT00128297 - Completed
  Breast cancer patients with symptomatic bone metastases.
  
• Pamidronate Prophylaxis in Multiple Myeloma 30 mg/Month Versus 90 mg/Month
  ClinicalTrials.gov Identifier: NCT00376883 - Completed
  Multiple Myeloma
  
• Pamidronate to Treat Osteogenesis Imperfecta in Children
  ClinicalTrials.gov Identifier: NCT00005901 - Recruiting
  Osteogenesis Imperfecta
  
• Pamidronate, Vitamin D, and Calcium for the Bone Disease of Kidney and Heart Transplantation
  ClinicalTrials.gov Identifier: NCT00302627 - Active, not recruiting
  Transplant Bone Disease
  
• Pan-European Survey on the Under Treatment of Hypercholesterolemia
  ClinicalTrials.gov Identifier: NCT00542867 - Completed
  Hypercholesterolemia
  
• Pancreas Transplantation in Man
  ClinicalTrials.gov Identifier: NCT00156364 - Recruiting
  Diabetes Mellitus
  
• Pancreatic Cancer Genetic Epidemiology (PACGENE) Study
  ClinicalTrials.gov Identifier: NCT00526578 - Recruiting
  Pancreatic Cancer
  
• Pancreatic Cancer Serum and DNA Repository
  ClinicalTrials.gov Identifier: NCT00296114 - Recruiting
  Pancreas Cancer
  
• Pancreatic Enzymes to Restore Digestive Function in Malnourished Gastric Bypass Patients
  ClinicalTrials.gov Identifier: NCT00510744 - Not yet recruiting
  Obesity
  
• Pancreatic Islet Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00214786 - Recruiting
  Islet Cell Transplantation
  
• Pancreatic Islet Cell Transplantation - A Novel Approach to Immunosuppression
  ClinicalTrials.gov Identifier: NCT00530686 - Recruiting
  Islet Cell Transplantation; Type 1 Diabetes
  
• Pancreatic Islet Function, Insulin Sensitivity, and Chronic Complications in Pre-Diabetes
  ClinicalTrials.gov Identifier: NCT00172796 - Recruiting
  Prediabetic State; Obesity; Metabolic Syndrome X
  
• Pancreatic Islet Mass in Pregnancy
  ClinicalTrials.gov Identifier: NCT00548522 - Recruiting
  Type 1 Diabetes; Pregnancy
  
• Panic Disorder and Cardiac Risk
  ClinicalTrials.gov Identifier: NCT00168506 - Recruiting
  Panic Disorder
  
• Panic Disorder Study
  ClinicalTrials.gov Identifier: NCT00038896 - Active, not recruiting
  Panic Disorder
  
• Panic Disorder Study
  ClinicalTrials.gov Identifier: NCT00044772 - Active, not recruiting
  Panic Disorder
  
• Panitumumab DDI Irinotecan
  ClinicalTrials.gov Identifier: NCT00563316 - Not yet recruiting
  Metastatic Colorectal Cancer
  
• Panitumumab in Combination With Irinotecan Chemotherapy as 2nd-Line Therapy in Subjects With mCRC
  ClinicalTrials.gov Identifier: NCT00475293 - Recruiting
  Metastatic Colorectal Cancer
  
• Panitumumab in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00112944 - Recruiting
  adenocarcinoma of the colon; adenocarcinoma of the rectum; stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; ...
  
• Panitumumab Plus Chemoradiotherapy and Induction Chemotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00513383 - Recruiting
  Squamous Cell Carcinoma of the Head and Neck; Basaloid Squamous Cell Carcinoma; Undifferentiated Carcinoma; Adenosquamous Cell Carcinoma
  
• Panitumumab Plus FOLFIRI in First-Line Treatment of Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00508404 - Recruiting
  Metastatic Colorectal Cancer
  
• Panitumumab Regimen Evaluation in Colorectal Cancer to Estimate Primary Response to Treatment
  ClinicalTrials.gov Identifier: NCT00411450 - Recruiting
  Colon Cancer; Colorectal Cancer; Rectal Cancer; Cancer; Metastatic Cancer; Metastatic Colorectal Cancer; Oncology
  
• PANORAMA Observational Study
  ClinicalTrials.gov Identifier: NCT00382525 - Recruiting
  Arrhythmia; Cardiac Pacemaker, Artificial; Defibrillators, Implantable
  
• PANVAC™-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer after Failing a Gemcitabine-Containing Regimen
  ClinicalTrials.gov Identifier: NCT00088660 - Active, not recruiting
  Pancreatic Cancer
  
• Papillary Serous Carcinoma of the Endometrium
  ClinicalTrials.gov Identifier: NCT00515073 - Recruiting
  Endometrial Cancer
  
• Papilloma Virus Vaccine Therapy in Treating Young Patients With Recurrent Papilloma of the Larynx
  ClinicalTrials.gov Identifier: NCT00002454 - Active, not recruiting
  respiratory papillomas
  
• Papua New Guinean Duffy Negativity And Vivax Malar
  ClinicalTrials.gov Identifier: NCT00138489 - Suspended
  Malaria
  
• PAR Family Polymorphisms and Placental Invasion Disorders
  ClinicalTrials.gov Identifier: NCT00425867 - Not yet recruiting
  Miscarriage, Recurrent; Premature Labor
  
• PAR-101/OPT-80 Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD)
  ClinicalTrials.gov Identifier: NCT00314951 - Recruiting
  Clostridium Infections; Diarrhea
  
• PAR-101/OPT-80 Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD)
  ClinicalTrials.gov Identifier: NCT00468728 - Recruiting
  Clostridium Infections; Diarrhea
  
• Para-Aortic Lymph Nodal Staging and Evaluation of Treatment Outcome by 18F-Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) in Advanced Cancer Cervix
  ClinicalTrials.gov Identifier: NCT00193752 - Recruiting
  Cancer of Cervix; Cervical Cancer; Cancer of the Cervix; Cervix Cancer
  
• Paracetamol and Endothelial Function in Patients With Stable Coronary Artery Disease
  ClinicalTrials.gov Identifier: NCT00534651 - Recruiting
  Coronary Arteriosclerosis; Endothelial Function
  
• Paracetamol Oral Paediatric Suspension at 4.8% : Study of Acceptability and Safety.
  ClinicalTrials.gov Identifier: NCT00434681 - Completed
  Fever; Pain
  
• Paracor Ventricular Support System (PVSS) for Patients With Heart Failure
  ClinicalTrials.gov Identifier: NCT00291551 - Completed
  Heart Failure, Congestive
  
• Paradigm I Clinical Trial: Study of the PFX Closure System in Subjects With Cryptogenic Stroke, Transient Ischemia Attack or Paradoxical Embolism
  ClinicalTrials.gov Identifier: NCT00196027 - Active, not recruiting
  Patent Foramen Ovale
  
• Parallel Group, Placebo-Controlled, Tolerability, Safety, and Efficacy Study of OPC-14117 in HIV Dementia
  ClinicalTrials.gov Identifier: NCT00002148 - Completed
  Cognitive Disorders; HIV Infections
  
• Parallel-Group Comparative Study of GONAL-F (SJ-0021) and Purified Pituitary Gonadotropin in Subjects With Amenorrhea 1 or Anovulatory Cycles
  ClinicalTrials.gov Identifier: NCT00467480 - Recruiting
  Infertility
  
• Parameters Associated With the Emergence of Resistance to Ciprofloxacin in Human Commensal Flora
  ClinicalTrials.gov Identifier: NCT00190151 - Terminated
  Healthy Volunteers
  
• Paraoxonase and LDL Oxidation in Carotid Artery Disease
  ClinicalTrials.gov Identifier: NCT00011258 - Completed
  Carotid Stenosis
  
• Paraplegic Cycling: Improving Health After Spinal Cord Injury
  ClinicalTrials.gov Identifier: NCT00204100 - Active, not recruiting
  Spinal Cord Injury
  
• Parasitic Infections of the Gastrointestinal Tract
  ClinicalTrials.gov Identifier: NCT00001162 - Recruiting
  Amebiasis; Cryptosporidiosis; Giardiasis; Parasitic Disease; Parasitic Intestinal Disease
  
• Parathyroid and Thymus Transplantation in DiGeorge
  ClinicalTrials.gov Identifier: NCT00566488 - Active, not recruiting
  DiGeorge Syndrome; Hypoparathyroidism
  
• Parathyroid Hormone (PTH) for Osteoporosis in Postmenopausal Women
  ClinicalTrials.gov Identifier: NCT00086619 - Active, not recruiting
  Postmenopausal Osteoporosis; Osteoporosis
  
• Parathyroid Hormone (PTH) with Alendronate for Osteoporosis
  ClinicalTrials.gov Identifier: NCT00005006 - Active, not recruiting
  Osteoporosis
  
• Parathyroid Hormone Levels in Relation to the Phosphorus Content of Meals
  ClinicalTrials.gov Identifier: NCT00018135 - Completed
  Renal Failure
  
• Paravertebral Block for Breast Surgery
  ClinicalTrials.gov Identifier: NCT00131170 - Completed
  Breast Cancer
  
• Paravertebral Block, an Adjunct to General Anaesthesia for Breast Surgery?
  ClinicalTrials.gov Identifier: NCT00547989 - Recruiting
  Breast Cancer
  
• Parecoxib In Post Surgery (Hemicolectomy) Pain
  ClinicalTrials.gov Identifier: NCT00139607 - Terminated
  colectomy
  
• Parecoxib in Renal Colic
  ClinicalTrials.gov Identifier: NCT00139646 - Terminated
  Colic
  
• Parent Psychoeducation and Cognitive Behavior Therapy for Latino Adolescents with Depression
  ClinicalTrials.gov Identifier: NCT00118469 - Recruiting
  Depression
  
• Parent Training to Promote Early Identification and Treatment of Childhood Behavioral Disorders
  ClinicalTrials.gov Identifier: NCT00402857 - Recruiting
  Attention Deficit Disorder With Hyperactivity; Attention Deficit and Disruptive Behavior Disorders
  
• Parent-Augmented Cognitive Behavioral Therapy to Treat Children With Specific Phobias
  ClinicalTrials.gov Identifier: NCT00509951 - Recruiting
  Anxiety Disorders; Specific Phobia
  
• Parent-Provider Intervention for Improving Medication Adherence in Children With Attention Deficit Hyperactivity Disorder
  ClinicalTrials.gov Identifier: NCT00429221 - Not yet recruiting
  Attention Deficit Disorder With Hyperactivity
  
• Parent-Youth Teamwork in Pediatric Asthma Management
  ClinicalTrials.gov Identifier: NCT00166582 - Completed
  Asthma
  
• Parental Bereavement Study Among Couples Coping Traumatic Loss of a Child
  ClinicalTrials.gov Identifier: NCT00447174 - Recruiting
  Bereaved Parents
  
• Parental Involvement and Children's Extra-Familial Contexts
  ClinicalTrials.gov Identifier: NCT00538252 - Recruiting
  Prevention of Drug Abuse Risk
  
• Parental knowledge and beliefs about infant sleep position
  ClinicalTrials.gov Identifier: NCT00005567 - Completed
  Sudden Infant Death Syndrome
  
• Parental Permission and Adolescent Assent and Decision Making in Clinical Research
  ClinicalTrials.gov Identifier: NCT00571311 - Recruiting
  Adolescents
  
• Parenteral Hydration in Advanced Cancer Patients-A Randomized Controlled Trial
  ClinicalTrials.gov Identifier: NCT00423722 - Recruiting
  Advanced Cancer; Dehydration
  
• Parenting Matters: Helping Parents with Young Children
  ClinicalTrials.gov Identifier: NCT00133055 - Recruiting
  Sleep Problems; Behavior Problems; Psychosocial
  
• Parenting Videos In Primary Care
  ClinicalTrials.gov Identifier: NCT00558987 - Not yet recruiting
  Discipline Attitudes; Discipline Practices
  
• ParentLink: Better and Safer Emergency Care for Children
  ClinicalTrials.gov Identifier: NCT00457600 - Completed
  Otitis Media; Urinary Tract Infection; Asthma; Head Injury
  
• Parents at the Center: Information Management in ADHD - Clinical Trial
  ClinicalTrials.gov Identifier: NCT00543257 - Recruiting
  Health Literacy; Attention Deficit Disorder With Hyperactivity; Computer Literacy; Information Management; Parents
  
• Parents Helping Infants Study: Educational Intervention to Change the Knowledge, Attitudes and Behaviour of New Parents About Early Infant Crying
  ClinicalTrials.gov Identifier: NCT00175422 - Recruiting
  Shaken Baby Syndrome
  
• Parents Matter!: Interventions to Promote Effective Parent-Child Communication
  ClinicalTrials.gov Identifier: NCT00137943 - Active, not recruiting
  HIV; Sexually Transmitted Disease; Pregnancy
  
• Paricalcitol and Gemcitabine in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00217477 - Recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Paricalcitol and Zoledronate in Treating Patients With Relapsed or Refractory Multiple Myeloma or Other Plasma Cell Disorders
  ClinicalTrials.gov Identifier: NCT00258258 - Recruiting
  Multiple Myeloma and Plasma Cell Neoplasm
  
• Paricalcitol in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00064376 - Active, not recruiting
  Chronic Myelomonocytic Leukemia; Myelodysplastic Syndromes
  
• PARIS or PAtch RIng Study: A Trial to Evaluate NuvaRing Versus OrthoEvra
  ClinicalTrials.gov Identifier: NCT00269620 - Completed
  Contraception
  
• Parity and Serum Lipids in White and Hispanic Women
  ClinicalTrials.gov Identifier: NCT00005405 - Completed
  Atherosclerosis; Cardiovascular Diseases; Heart Diseases
  
• Parkin Mutations
  ClinicalTrials.gov Identifier: NCT00136721 - Active, not recruiting
  Parkinson''s Disease
  
• Parkinson's Disease Evaluated by PET and the Effect of Memantine
  ClinicalTrials.gov Identifier: NCT00375778 - Completed
  Parkinson's Disease
  
• Parkinson's Disease Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole
  ClinicalTrials.gov Identifier: NCT00460148 - Completed
  Parkinson's Disease
  
• Parkinson's Disease Registry of the Muhammad Ali Parkinson Center
  ClinicalTrials.gov Identifier: NCT00217321 - Recruiting
  Parkinson's Disease
  
• Parkinson's disease treatment with coenzyme Q10
  ClinicalTrials.gov Identifier: NCT00004731 - Completed
  Parkinson's Disease
  
• Parkinson's Diseases Susceptibility Genes and Pesticides
  ClinicalTrials.gov Identifier: NCT00044590 - Recruiting
  Parkinson's Disease
  
• Parkinson's Genes and Environment Study
  ClinicalTrials.gov Identifier: NCT00367900 - Recruiting
  Parkinson's Disease (PD)
  
• Parkinson's Research: The Organized Genetics Initiative (PROGENI)
  ClinicalTrials.gov Identifier: NCT00086073 - Recruiting
  Parkinson Disease
  
• Parotid-Sparing Intensity-Modulated Radiation Therapy Compared With Conventional Radiation Therapy in Treating Patients With Oropharyngeal or Hypopharyngeal Cancer Who Are at High Risk of Radiation-Induced Xerostomia
  ClinicalTrials.gov Identifier: NCT00081029 - Recruiting
  Hypopharyngeal Cancer; oral complications of chemotherapy and head and neck radiation; Oropharyngeal Cancer; radiation toxicity
  
• Paroxetine and Interpersonal Psychotherapy for Maintaining Health and Well-Being in Elderly Individuals With Depression
  ClinicalTrials.gov Identifier: NCT00178100 - Completed
  Unipolar Depression
  
• Paroxetine for Comorbid Social Anxiety Disorder and Alcoholism
  ClinicalTrials.gov Identifier: NCT00246441 - Active, not recruiting
  Social Anxiety Disorder; Social Phobia; Alcohol Use Disorder; Alcohol Abuse; Alcohol Dependence
  
• Paroxetine for the Treatment of Interferon Related Side Effects for Hepatitis C
  ClinicalTrials.gov Identifier: NCT00209118 - Active, not recruiting
  Hepatitis C; Depression; Interferon-Alpha Associated Side Effects
  
• Paroxetine in the Treatment of Chronic Primary Insomnia
  ClinicalTrials.gov Identifier: NCT00178048 - Completed
  Primary Insomnia; Depression
  
• Paroxetine Treatment in Outpatients With Comorbid PTSD and Substance Dependence
  ClinicalTrials.gov Identifier: NCT00330239 - Completed
  PTSD
  
• Paroxetine Versus Bupropion for Treating People With High-Risk Major Depressive Disorder
  ClinicalTrials.gov Identifier: NCT00429169 - Recruiting
  Depression
  
• Paroxetine vs Placebo Combined With Aerobic Exercise or Relaxation in Panic Disorder
  ClinicalTrials.gov Identifier: NCT00540098 - Completed
  Panic Disorder
  
• Paroxetine-CR to Treat Post-Traumatic Stress Disorder (PTSD) Symptomatic After Initial Exposure Therapy
  ClinicalTrials.gov Identifier: NCT00215163 - Completed
  Stress Disorders, Post-Traumatic
  
• Paroxetine-Referenced Study Evaluating Three Doses of DVS SR in Outpatients With MDD
  ClinicalTrials.gov Identifier: NCT00445679 - Recruiting
  Depressive Disorder, Major
  
• Paroxysmal Atrial Fibrillation: Role of Inflammation and Effect of Statins
  ClinicalTrials.gov Identifier: NCT00321802 - Recruiting
  Atrial Fibrillation
  
• Pars Plana Vitrectomy for Diabetic Fibrovascular Proliferation With and Without Internal Limiting Membrane Peeling
  ClinicalTrials.gov Identifier: NCT00556244 - Recruiting
  Patients With Proliferative Diabetic Retinopathy Who Have Active Fibrovascular Proliferation
  
• Part A: Radiolabel Study With GSK786034 Part B: Single Dose of GSK786034
  ClinicalTrials.gov Identifier: NCT00478725 - Recruiting
  Cancer
  
• Partial Breast Irradiation (PBI) for Selected Patients With Early Breast Cancer
  ClinicalTrials.gov Identifier: NCT00325598 - Recruiting
  Breast Neoplasms
  
• Partial Breast Irradiation Using Accelerated Intensity Modulated Radiotherapy in Early Stage Breast Cancer After Breast-Conserving Surgery
  ClinicalTrials.gov Identifier: NCT00581529 - Active, not recruiting
  Breast Cancer
  
• Partial Breast Irradiation With Interstitial High Dose Rate Brachytherapy
  ClinicalTrials.gov Identifier: NCT00499057 - Recruiting
  Breast Cancer
  
• Partial Breast Irradiation With Multi-Catheter Brachytherapy for pT1-2pN0 Breast Cancer After Breast Conserving Surgery
  ClinicalTrials.gov Identifier: NCT00392184 - Active, not recruiting
  Breast Cancer
  
• Partial Breast Radiation Therapy in Treating Women Undergoing Breast-Conserving Therapy for Early Stage Breast Cancer
  ClinicalTrials.gov Identifier: NCT00527293 - Recruiting
  Breast Cancer
  
• Partial Breast Radiation to the Lumpectomy Cavity With IMRT in Elderly Women
  ClinicalTrials.gov Identifier: NCT00337064 - Recruiting
  Stage I Breast Cancer
  
• Partial Double-Blind, Placebo-Controlled Study to Assess the Effect of Anastrozole on the Endometrium in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00467493 - Recruiting
  Menstruation Disorders
  
• Partial Word Knowledge Growth in Children With LLD
  ClinicalTrials.gov Identifier: NCT00547833 - Recruiting
  Language Disorders
  
• Partially Blind Study to Evaluate Immunogenicity & Safety of GSK Bios' HPV Vaccine 580299 in Healthy Women Aged 9-25 Yrs
  ClinicalTrials.gov Identifier: NCT00541970 - Recruiting
  Papillomavirus Infections; Cervical Cancer
  
• Partially Matched Stem Cell Transplantation for Patients With Refractory Severe Aplastic Anemia or Refractory Cytopenias
  ClinicalTrials.gov Identifier: NCT00244010 - Recruiting
  Anemia, Aplastic; Neutropenia; Diamond-Blackfan Anemia; Thrombocytopenia
  
• Partially-Blind (Observer-Blind) Study of Safety and Immunogenicity of Two Malaria Vaccines in Ghanaian Children
  ClinicalTrials.gov Identifier: NCT00360230 - Active, not recruiting
  Plasmodium Falciparum Malaria
  
• Participant Database for Autism Research Studies
  ClinicalTrials.gov Identifier: NCT00549731 - Recruiting
  Autism Spectrum Disorder; Developmental Language Disorders
  
• Participant Features Affecting Depression Treatment
  ClinicalTrials.gov Identifier: NCT00073697 - Completed
  Depression
  
• Particulate Reduction Education in City Homes
  ClinicalTrials.gov Identifier: NCT00466024 - Recruiting
  Asthma
  
• Partner Notification in Primary Care
  ClinicalTrials.gov Identifier: NCT00112255 - Completed
  Chlamydia Infections
  
• Partner Notification Intervention for STD Clinics.
  ClinicalTrials.gov Identifier: NCT00207571 - Active, not recruiting
  Contact Tracing
  
• PARTNER: Panitumumab Added to Regimen for Treatment of Head aNd Neck Cancer Evaluation of Response
  ClinicalTrials.gov Identifier: NCT00454779 - Recruiting
  Metastatic or Recurrent Squamous Cell Carcinoma of Head and Neck
  
• PARTNERS HF: Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure
  ClinicalTrials.gov Identifier: NCT00279955 - Active, not recruiting
  Heart Failure, Congestive
  
• Partners in Dementia Care
  ClinicalTrials.gov Identifier: NCT00291161 - Recruiting
  Dementia; Alzheimer Disease
  
• Partnership for Healthy Seniors
  ClinicalTrials.gov Identifier: NCT00379743 - Recruiting
  Breast Cancer; Colon Cancer; Rectum Cancer; Cervix Cancer; Prostate Cancer
  
• Partnership on Nutrition and HIV/AIDS Research in Tanzania: Exploratory Research Study on Selenium and HIV Infection
  ClinicalTrials.gov Identifier: NCT00197561 - Active, not recruiting
  HIV Infections; Pregnancy Complications
  
• Partnership Programs to Reduce Cardiovascular Disparities - Baltimore Partnership
  ClinicalTrials.gov Identifier: NCT00101478 - Recruiting
  Cardiovascular Diseases; Heart Diseases; Diabetes Mellitus; Hypertension
  
• Partnership Programs to Reduce Cardiovascular Disparities - Deep South Partnerships for Prevention of CVD Disparities
  ClinicalTrials.gov Identifier: NCT00101491 - Recruiting
  Cardiovascular Diseases; Heart Diseases
  
• Partnership Programs to Reduce Cardiovascular Disparities - Heart Failure Disparities in Native Hawaiians
  ClinicalTrials.gov Identifier: NCT00101465 - Recruiting
  Cardiovascular Diseases; Heart Failure; Heart Diseases
  
• Partnership Programs to Reduce Cardiovascular Disparities - Hypertension Education and Treatment (HEAT)
  ClinicalTrials.gov Identifier: NCT00101504 - Not yet recruiting
  Cardiovascular Diseases; Hypertension; Heart Diseases
  
• Partnership Programs to Reduce Cardiovascular Disparities - Latinos Using Cardio Health Actions to Reduce Risk
  ClinicalTrials.gov Identifier: NCT00101530 - Recruiting
  Cardiovascular Diseases; Heart Diseases; Hypertension; Diabetes Mellitus
  
• Partnership Programs to Reduce Cardiovascular Disparities - Morehouse-Emory Partnership
  ClinicalTrials.gov Identifier: NCT00101517 - Not yet recruiting
  Cardiovascular Diseases; Heart Diseases; Obesity; Metabolic Syndrome X
  
• Partnership Programs to Reduce Cardiovascular Disparities- Morehouse- Emory Partnership
  ClinicalTrials.gov Identifier: NCT00336869 - Recruiting
  Metabolic Symdrome
  
• PASTA 4: Physical Activity and Self-Management Trial for HF and COPD
  ClinicalTrials.gov Identifier: NCT00467298 - Not yet recruiting
  Chronic Obstructive Pulmonary Disease (COPD); Heart Failure
  
• Patch Contraception Study
  ClinicalTrials.gov Identifier: NCT00185354 - Completed
  Contraception
  
• Patching for Lazy Eye: Trial to Evaluate Daily Patching Amounts
  ClinicalTrials.gov Identifier: NCT00274664 - Completed
  Amblyopia
  
• Patellar Resurfacing in Total Knee Arthroplasty. A Prospective, Randomised and Double Blind Study.
  ClinicalTrials.gov Identifier: NCT00553982 - Recruiting
  Arthroplasty,Replacement,Knee; Osteoarthritis,Knee; Pain; Patella
  
• Patent Foramen Ovale Closure or Anticoagulants Versus Antiplatelet Therapy to Prevent Stroke Recurrence
  ClinicalTrials.gov Identifier: NCT00562289 - Not yet recruiting
  Ischemic Stroke; Patent Foramen Ovale; Atrial Septal Aneurysm; Migraine
  
• Patent Foramen Ovale Closure With the AMPLATZER PFO OCCLUDER in Patients With Recurrent Cryptogenic Stroke
  ClinicalTrials.gov Identifier: NCT00557479 - Recruiting
  Paradoxical Embolic Stroke; Patent Foramen Ovale
  
• PaTH Study: Parathyroid Hormone and Alendronate for Osteoporosis
  ClinicalTrials.gov Identifier: NCT00005005 - Active, not recruiting
  Osteoporosis
  
• Pathobiological Determinants of Atherosclerosis in Youth (PDAY)
  ClinicalTrials.gov Identifier: NCT00005679 - Active, not recruiting
  Cardiovascular Diseases; Atherosclerosis; Heart Diseases; Coronary Disease; Coronary Arteriosclerosis
  
• Pathogen Identification of Bacterial Pneumonia Via DNA Detection
  ClinicalTrials.gov Identifier: NCT00567827 - Not yet recruiting
  Pneumonia
  
• Pathogen Specific Immunity in Patients With Sarcoidosis
  ClinicalTrials.gov Identifier: NCT00217789 - Recruiting
  Sarcoidosis
  
• Pathogenesis and Cerebrovascular Manifestations of Septic Encephalopathy
  ClinicalTrials.gov Identifier: NCT00410111 - Completed
  Sepsis
  
• Pathogenesis and Genetics of Environmental Asthma Ozone Study
  ClinicalTrials.gov Identifier: NCT00574158 - Recruiting
  No Disease Being Studied. Evaluating Response in Healthy Subjects to an Exposure to Air Pollutant.
  
• Pathogenesis of Adverse Drug Reactions
  ClinicalTrials.gov Identifier: NCT00224952 - Recruiting
  Seizures
  
• Pathogenesis of Liver Fluke Induced Cancer in Thailand
  ClinicalTrials.gov Identifier: NCT00472602 - Recruiting
  Opisthorchis Viverrini
  
• Pathophysiological Mechanisms of Hepatopulmonary Influence in the Fontan Circulation
  ClinicalTrials.gov Identifier: NCT00263406 - Completed
  Children With a Univentricular Heart Undergoing Surgery for Creation of a Fontan Circulation
  
• Pathophysiological Mechanisms of Hypertensive LVH:Optimising Regression
  ClinicalTrials.gov Identifier: NCT00518479 - Completed
  Hypertension; Left Ventricular Hypertrophy
  
• Pathophysiological Study of Allergic Contact Dermatitis to Para-Phenylenediamine (PPD). Analysis of Cellular and Molecular Targets in Skin Inflammation
  ClinicalTrials.gov Identifier: NCT00445029 - Recruiting
  Allergic Contact Dermatitis
  
• Pathophysiological Subtyping of Abnormalities in Cocaine Dependence - 9
  ClinicalTrials.gov Identifier: NCT00015275 - Completed
  Cocaine-Related Disorders; Substance-Related Disorders
  
• Pathophysiology and Clinical Relevance of Endotoxin Tolerance in Humans
  ClinicalTrials.gov Identifier: NCT00246714 - Recruiting
  Endotoxemia
  
• Pathophysiology of Chronic Wounds
  ClinicalTrials.gov Identifier: NCT00006437 - Completed
  Healthy; Skin Ulcer
  
• Pathways
  ClinicalTrials.gov Identifier: NCT00000545 - Completed
  Cardiovascular Diseases; Sedentary Behaviors; Obesity
  
• Pathways to Vocational Rehabilitation: Enhancing Entry and Retention
  ClinicalTrials.gov Identifier: NCT00223834 - Recruiting
  Unemployment; Poverty
  
• Patient Acceptance of Whole Body Magnetic Resonance Angiography.
  ClinicalTrials.gov Identifier: NCT00556101 - Recruiting
  Atherosclerosis; Intermittent Claudication; MRI
  
• Patient and Provider Attitudes in the Healthcare Context
  ClinicalTrials.gov Identifier: NCT00404027 - Recruiting
  Diabetes Mellitus; Hypertension
  
• Patient Based Strategy to Reduce Errors in Diabetes Care
  ClinicalTrials.gov Identifier: NCT00262197 - Completed
  Diabetes Mellitus
  
• Patient Centered Communication Training to Reduce Antibiotic Use in Acute Respiratory Tract Infections
  ClinicalTrials.gov Identifier: NCT00105248 - Completed
  Respiratory Tract Infections
  
• Patient Centered Randomized Controlled Trial
  ClinicalTrials.gov Identifier: NCT00233077 - Recruiting
  Early-Stage Breast Cancer
  
• Patient Computer Dialog in Primary Care
  ClinicalTrials.gov Identifier: NCT00386776 - Not yet recruiting
  Medical History Taking
  
• Patient Controlled Oral Analgesia for Postoperative Pain Management After Total Knee Replacement
  ClinicalTrials.gov Identifier: NCT00221936 - Recruiting
  Self-Administered Versus Nurse Administered Pain Medication.
  
• Patient Education in NorthTrondelag Hospital Trust
  ClinicalTrials.gov Identifier: NCT00326222 - Recruiting
  Diabetes
  
• Patient Education in Preventing Nausea and Vomiting in Cancer Patients Receiving Chemotherapy
  ClinicalTrials.gov Identifier: NCT00005994 - Active, not recruiting
  nausea and vomiting
  
• Patient Education in Rheumatoid Arthritis and Osteoarthritis
  ClinicalTrials.gov Identifier: NCT00000414 - Completed
  Rheumatoid Arthritis; Osteoarthritis
  
• Patient Evaluation for Head and Neck Surgery Branch Studies
  ClinicalTrials.gov Identifier: NCT00011492 - Recruiting
  Head and Neck Cancer
  
• Patient Experiences in Rheumatology
  ClinicalTrials.gov Identifier: NCT00346710 - Active, not recruiting
  Rheumatic Disease
  
• Patient Navigator Research Program
  ClinicalTrials.gov Identifier: NCT00375024 - Recruiting
  Breast Cancer; Colon Cancer
  
• PAtient NOtifier Feature for Reduction of Anxiety
  ClinicalTrials.gov Identifier: NCT00559559 - Not yet recruiting
  Tachycardia, Ventricular
  
• Patient Plasma Response and Outcome in Septic Shock with Thrombocytopenia Associated Multiple Organ Failure in Children
  ClinicalTrials.gov Identifier: NCT00118664 - Recruiting
  Septic Shock; Thrombocytopenia; Multiple Organ Failure
  
• Patient Position and Impact on Colonoscopy Time
  ClinicalTrials.gov Identifier: NCT00314418 - Completed
  Colonoscopy
  
• Patient Preference of h-Patch vs. Pen or Needle/Syringe as Insulin Administration Device
  ClinicalTrials.gov Identifier: NCT00453934 - Terminated
  Type 1 Diabetes; Type 2 Diabetes
  
• Patient Preference Study
  ClinicalTrials.gov Identifier: NCT00576342 - Recruiting
  Glaucoma; Ocular Hypertension
  
• Patient Preference With Visicol Tablet Preparation for Colonoscopy
  ClinicalTrials.gov Identifier: NCT00318305 - Completed
  Preparation for Colonoscopy
  
• Patient Profiling and Provider Feedback to Reduce Adverse Drug Events
  ClinicalTrials.gov Identifier: NCT00013143 - Completed
  Adverse Drug Reaction Reporting Systems
  
• Patient Provider Partnership: Improving Diabetes Care in the Community
  ClinicalTrials.gov Identifier: NCT00167284 - Completed
  Diabetes
  
• Patient Registry to Study the Tined Lead Used With the InterStim System For Urinary Control
  ClinicalTrials.gov Identifier: NCT00225966 - Active, not recruiting
  Urge Incontinence; Urinary Retention
  
• Patient Research In Self-Management of Asthma (PRISMA)
  ClinicalTrials.gov Identifier: NCT00411346 - Completed
  Asthma
  
• Patient Satisfaction & Quality Of Life in Patients With Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00473798 - Recruiting
  Cervical Cancer
  
• Patient Selection for Hypoxia Modifying Treatments in Larynx Carcinomas
  ClinicalTrials.gov Identifier: NCT00160095 - Recruiting
  Larynx Cancer
  
• Patient Sleep Position Questionnaire
  ClinicalTrials.gov Identifier: NCT00338013 - Recruiting
  Sleep
  
• Patient Tolerability Study of GSK163090
  ClinicalTrials.gov Identifier: NCT00559299 - Recruiting
  Major Depressive Disorder
  
• Patient's Anastrozole Compliance to Therapy Programme
  Clinic